InsidersTradesSigma
Track the *ST美谷 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, *ST美谷 has published 9 reports. Market capitalisation: €5.4bn. The latest transaction was reported on 1 July 2022 (Sale). Among the most active insiders: 徐巍. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
*ST美谷 is a company listed on the XSHE market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products.